BioSpace News Archive

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATF) (FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that Dr. Jennifer Bath, CEO of IPA, is scheduled to appear today as a guest on Bloomberg Technology with host Emily Chang at approximately 5:10 p.m. ET.

The American Academy of Orthopaedic Surgeons (AAOS) announced a plan to launch a Fracture & Trauma Registry (FTR) and begin collecting data on five of the more common fractures in the United States.

OnLume Surgical, a medical device company developing novel imaging systems for use during surgery, was recognized as one of the ten (10) finalists for the 2020 Wisconsin Innovation Awards.

Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, October 29, 2020 at 4:30 p.m., Eastern Time, to discuss the Company’s operating results for the quarter ended September 30, 2020 and provide an operational update. Final operating results for the quarter ended September 30, 2020 will be released at 4:05 p.m. that day. To participate in the conference call dial (877) 702-4565 (domestic) or (647) 689-5532 (intern

Baylor College of Medicine and The Menninger Clinic jointly announce the hiring of Robert J. Boland , M.D., as vice chairman of the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine and chief of staff at The Menninger Clinic. Boland joins the organizations on January 4, 2021 , after tran

The 3,400 registered nurses of Brigham and Women’s Hospital, represented by the Massachusetts Nurses Association, have decided to take public their concerns about how the hospital is hand

Hyasynth, a sustainable biotechnology company, takes top spot from global competitors by making the first ever sale of cannabidiol (CBD) produced and extracted from yeast.

KARL STORZ Endoscopy-America, Inc., a leader in minimally invasive surgical technology and related medical systems, has been awarded a major contract by the Defense Logistics Agency under the Patient Monitoring and Capital Equipment solicitation SPE2D1-17-R-0001.

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Scot Roberts, Ph.D., Chief Scientific Officer of Altimmune, Inc., presented an overview of the Company’s AdCOVID and T-COVID intranasal vaccine and therapeutic candidates during a special COVID-19 virtual session of the World Vaccine Congress Washington, taking place September 28 – October 1, 2020. A link to Dr. Roberts’ presentation is availab

- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs ™ ), today announced that Sarah Boyce , President and Chief Executive Officer, Arthur Levin , Ph.D., Chief Scientific Officer, and Mike MacLean , Chi